Rare diseases have a low incidence in the population of less than 1 in every 200 inhabitants.

However, together, they affect around 7% of the population, which equates to some 3 million people in Spain. They are chronic, highly diverse diseases with high morbidity that often lead to an early death. An ability to reach an early and accurate diagnosis can make a qualitative difference as regards management of the patient, thus improving their quality of life, prognosis and evolution.

IMEGEN provides access to the most appropriate genetic tests, thereby providing an accurate and reliable diagnosis.